SSCRIMED
Healthcare buyerUnderstand SCRIMED quicklyDemo, pilot, or pricing ownerConvert demo interest into a priced pilot pathInvestor, strategic partner, or faith-based clinic sponsorUnderstand SCRIMED's investable and sellable value safely
Pilot Programs

sellable-now · 45-60 days

AI Governance + Interoperability Readiness Pilot

Create an actionable AI asset, governance, interoperability, and production-readiness register before healthcare AI deployment.

Duration45-60 days
EngagementRecommended readiness range: $75k-$225k based on organizations, workflows, standards scope, and review depth
Included demos2
Decision metrics4
Commercial path2 demos

Target buyer

CIO, compliance, security, clinical governance, and integration leadership teams

Recommended readiness range: $75k-$225k based on organizations, workflows, standards scope, and review depth

Request this pilot
01AI Asset Registry and shadow-AI findings
02Governance and approval gap report
03Standards, connector, and conformance target map
04Trust, audit, identity, and runtime safety decision register
05Executive remediation roadmap

Best demo entry paths

Use these demos to make the pilot conversation faster and easier for the buyer.

Interoperability Readiness Sprint

Atlas Interoperability Readiness Demo

CIOs, integration leaders, EHR teams, health tech platforms, and security teams.

$75k-$225k for readiness; production connector work requires separate reviewed scope.
  • No live healthcare data exchange, connector certification, trading-partner acceptance, or production mutation.
  • Redox-style integration economics prove connector work belongs in custom scope.
Open demo
TrustOS AI Governance Audit

AgentOS Governance Evaluation Demo

AI governance, compliance, innovation, clinical transformation, and executive leaders.

$75k-$225k for governance and interoperability readiness; protected pilot scope starts above this.
  • No live PHI ingestion, autonomous clinical execution, production connector access, or payer/patient action.
  • The demo proves governance structure, not autonomous live AI authority.
Open demo

Included product proof

Inspectable demos ground the pilot in real product surfaces.

Decision metric 01

AI assets and owners inventoried

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 02

High-risk governance gaps assigned

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 03

Interoperability targets and blockers approved

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 04

Deployment decision path made explicit

Measured against a buyer-approved operational baseline and governance boundary.

Activation requirements

The pilot starts only when buyer inputs and governance gates are explicit.

Buyer inputs

Required context

Business, workflow, and operating information needed to produce decision-grade evidence.

  • AI, integration, workflow, and vendor inventory
  • Security and compliance policies
  • Target standards and trading partners
  • Executive risk and deployment priorities
Governance gates

Required controls

Conditions that keep the engagement auditable, human-reviewed, and healthcare-safe.

  • Assessment access follows least privilege
  • No patient records required
  • Findings require accountable owner and disposition
  • Production authorization remains outside the assessment
Production exclusions

Not included

Capabilities that remain denied or require a separate protected-production approval path.

  • No certification claim
  • No live connector implementation
  • No production AI authorization
  • No clinical advice
ProposalDownload pilot proposal

Share the proposed scope, commercial model, metrics, inputs, gates, and exclusions.

StartRequest this pilot

Open the governed enterprise intake with the closest matching service offer selected.

ProofInspect all demos

Review the product evidence that can be packaged into the engagement.

CommercialReview pricing strategy

Inspect expansion paths from evaluation into protected pilot and enterprise license.

AcceleratorReview market alignment

Inspect benchmark context, price bands, and demo-to-pilot routing.